Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1998

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Oral contraceptives and cyproterone acetate in female acne treatment.

AUTHORS

Beylot C; Doutre MS; Beylot-Barry M

SOURCE

DERMATOLOGY. 1998;196(1):148-52.

ABSTRACT

In both men and women, acne may be related to an excessive hypersensitivity of the sebaceous end organ to

androgens. In women, the ovarian and adrenal production and the plasma transport of androgens may be implicated,

especially in late-onset, persistent acne or with associated hirsutism. Hormonal treatment is not generally the first

line in women with no clinical or biologic signs of hyperandrogenism; however, it may be indicated in young women

with mild acne who request contraception. Oral contraceptives that contain androgenic progestins such as

norgestrel or levonorgestrel should be avoided since they decrease sex hormone-binding globulin levels and thus

increase free testosterone. Preferable is a dose of 2 mg of cyproterone acetate, as contained in Dianette. In cases

of resistant acne in adult women and/or in female acne that relapses rapidly after treatment with Roaccutane, higher

doses of antiandrogen treatment may be required. In severe prepubertal acne presumed related to an adrenal

enzymatic block, hormonal treatment is strongly indicated and must be continued for at least 12 months. A topical

agent that combines an antiandrogen with an antimicrobial is under investigation. Systemic hormonal treatment

should remain mandatory, however, for acne related to an ovarian or adrenal hyperandrogenism. (PubHealth.info

Document ID: CONT2T 1-06)

PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives and cyproterone acetate in female acne

treatment.", is(are) Beylot C; Doutre MS; Beylot-Barry M. The source of this article is "DERMATOLOGY.

1998;196(1):148-52.". This article was published in 1998 in English language(s). (PubHealth.info® Document ID:

CONT2T 1-06. All rights reserved with PubHealth.info) PIN: 5001

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.